OMX Stockholm PI
987,83
|
1,87
|
0,19 %
|
Analysen zu OMX Stockholm PI-Werten
31.01.24 | Hennes & Mauritz AB Neutral | UBS AG | |
31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
31.01.24 | Nokia Buy | Deutsche Bank AG | |
30.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
30.01.24 | Volvo AB Buy | Deutsche Bank AG | |
30.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
29.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
29.01.24 | Volvo AB Neutral | JP Morgan Chase & Co. | |
29.01.24 | Nokia Hold | Jefferies & Company Inc. | |
26.01.24 | Volvo AB Neutral | JP Morgan Chase & Co. | |
26.01.24 | Volvo AB Sector Perform | RBC Capital Markets | |
26.01.24 | Volvo AB Sell | UBS AG | |
25.01.24 | ABB Neutral | JP Morgan Chase & Co. | |
25.01.24 | Nokia Underweight | Barclays Capital | |
25.01.24 | Nokia Neutral | UBS AG | |
25.01.24 | Nokia Hold | Jefferies & Company Inc. | |
25.01.24 | Volvo AB Sell | UBS AG | |
25.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
24.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
23.01.24 | Ericsson Neutral | UBS AG | |
23.01.24 | Ericsson Neutral | JP Morgan Chase & Co. | |
23.01.24 | Ericsson Buy | Jefferies & Company Inc. | |
22.01.24 | Volvo AB Neutral | JP Morgan Chase & Co. | |
19.01.24 | ABB Sector Perform | RBC Capital Markets | |
19.01.24 | Nokia Underweight | Barclays Capital | |
18.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
17.01.24 | Hennes & Mauritz AB Underperform | Bernstein Research | |
16.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
16.01.24 | AstraZeneca Sell | UBS AG | |
15.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
15.01.24 | Volvo AB Buy | Deutsche Bank AG | |
15.01.24 | ABB Neutral | JP Morgan Chase & Co. | |
15.01.24 | ABB Sector Perform | RBC Capital Markets | |
09.01.24 | ABB Hold | Jefferies & Company Inc. | |
08.01.24 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
04.01.24 | ABB Market-Perform | Bernstein Research | |
03.01.24 | AstraZeneca Overweight | Barclays Capital | |
03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. |